Preventing hepatitis B reactivation in immunosuppressed patients: is it time to revisit the guidelines?
Yazdany
Jinoos
J
Calabrese
Leonard
L
D005260:Female; D006509:Hepatitis B / Q000276:immunology* / Q000517:prevention & control; D006801:Humans; D016867:Immunocompromised Host; D007165:Immunosuppression Therapy / Q000009:adverse effects*; D008297:Male; D017410:Practice Guidelines as Topic; D012219:Rheumatology / Q000379:methods / Q000592:standards; D055502:Secondary Prevention; D014775:Virus Activation / Q000276:immunology*